Chief Business & Strat Officer
Thu, May 14, 2026
May 14
returned securities to the issuer in APLS
24,666 shares @ $0.00
Decreased holdings by -100.00%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology